E
IONS icon

Ergoteles’s Ionis Pharmaceuticals IONS Stock Holding History

Ergoteles’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-69,124
Closed -$2.56M – 1741
2022
Q2 		$2.56M Buy
69,124
+31,124
+82% +$1.17M 0.08% 259
2022
Q1 		$1.41M Buy
38,000
+30,045
+378% +$983K 0.05% 343
2021
Q4 		$242K Sell
7,955
-44,917
-85% -$1.41M 0.01% 939
2021
Q3 		$1.77M Sell
52,872
-123,381
-70% -$4.65M 0.07% 275
2021
Q2 		$7.03M Buy
+176,253
New +$6.9M 0.16% 174
2021
Q1 		– Sell
-70,129
Closed -$3.96M – 920
2020
Q4 		$3.96M Buy
+70,129
New +$3.49M 0.13% 168

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Ergoteles's IONS Position: Q3 2022 in Review

Ergoteles sold out of Ionis Pharmaceuticals (IONS) in Q3 2022, closing a stake of 69,124 shares — an estimated $2.56M sold.

Ergoteles first reported a position in IONS in Q4 2020 and held it in 6 quarters. The position peaked at $7.03M in Q2 2021. 349 funds tracked by Wall St. Rank hold IONS as of Q3 2022.

  • Ergoteles reported no remaining Ionis Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Ergoteles sold 69,124 Ionis Pharmaceuticals shares in Q3 2022, an estimated $2.56M.
  • Ergoteles first reported a position in Ionis Pharmaceuticals in Q4 2020 and held it in 6 quarters.
  • Ergoteles's Ionis Pharmaceuticals position peaked at $7.03M in Q2 2021.
  • 349 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.